XB

XBiotech Inc.

  • CIK: 0001626878
  • EIN: 00-0000000
  • Business address: 5217 WINNEBAGO LANE, BUILDING 4, SUITE 100, AUSTIN, Texas, 78744

Information

  • Mailing address
    5217 WINNEBAGO LANE, BUILDING 4, SUITE 100, AUSTIN, TX, 78744
  • Phone
    512-386-2900
  • State location
    Texas
  • State of incorporation
    N/A
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About XBiotech Inc.

XBiotech Inc. (CIK: 0001626878) is an American company incorporated in the state of Texas. Head office is located at 5217 WINNEBAGO LANE, BUILDING 4, SUITE 100, AUSTIN, Texas, 78744. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. XBiotech Inc. is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
HU ANGELA 0001966685 Feb-10-2023 officer: Principle Financial Officer
GUT THOMAS 0001640283 Feb-03-2020 10 percent owner
BAY STREET FINANCIAL S.A. 0001803399 Feb-03-2020 10 percent owner
Libby Peter 0001784088 Jul-10-2019 director
RENNES FONDATION 0001094515 Dec-21-2018 10 percent owner
MacAdam Donald H. 0001735261 Mar-20-2018 director
Waldin Jan-Paul 0001733176 Feb-27-2018 director
Guzman Benjamin 0001711298 Jul-01-2017 officer: Sr.VP Corp. Strategy & Finance
Benson Trey 0001679847 Aug-12-2016 officer: VP of Commercial Development
Choudhury Kalidip 0001681667 Aug-12-2016 officer: VP of Business Development
McCollough Dawn 0001675110 May-19-2016 officer: VP Clinical Operations
Whitehurst James Scott 0001673274 May-02-2016 officer: Chief Financial Officer
MCKENZIE W THORPE 0001211462 Mar-17-2016 director, 10 percent owner
SIMARD JOHN 0001639078 Mar-17-2016 director, 10 percent owner
THORNBURG KELLY 0001644508 Jun-08-2015 officer: SVP of Operations
BONANNI FABRIZIO 0001183903 Apr-14-2015 director
VASELLA DANIEL 0001189152 Apr-14-2015 director
GONZALEZ NORMA I 0001638758 Apr-14-2015 officer: Vice President, Quality
COMBS DAVID J 0001638761 Apr-14-2015 officer: Vice President, Manufacturing
SHIVASWAMY SUSHMA 0001638762 Apr-14-2015 officer: VP of R&D
HAN QUEENA 0001638986 Apr-14-2015 officer: VP of Fin & HR, Secretary
STECHER MICHAEL 0001639077 Apr-14-2015 officer: Medical Director

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XBiotech Inc.

Filings Format Description Filed/Effective File/Film Number
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000950170-24-076084 ( Act) Size: 5 KB		 Jun-21-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000950170-24-076082 ( Act) Size: 5 KB		 Jun-21-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000950170-24-076081 ( Act) Size: 5 KB		 Jun-21-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000950170-24-076080 ( Act) Size: 5 KB		 Jun-21-2024

8-K Document

Current report filing

Acc-no: 0001171843-24-003541 (34 Act) Size: 182 KB		 Jun-20-2024

001-37347

241055102
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001171843-24-002746 (34 Act) Size: 2885 KB		 May-10-2024

001-37347

24933516
ARS Document

Annual report to security holders

Acc-no: 0001193125-24-127586 (34 Act) Size: 1120 KB		 May-01-2024

001-37347

24903799
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001193125-24-127584 (34 Act) Size: 387 KB		 May-01-2024

001-37347

24903763
DEF 14A Document

Definitive proxy statements

Acc-no: 0001193125-24-127578 (34 Act) Size: 736 KB		 May-01-2024

001-37347

24903730
10-K/A Document

Amendment to Annual report pursuant to section 13 and 15(d)

Acc-no: 0001193125-24-127331 (34 Act) Size: 342 KB		 May-01-2024

001-37347

24902642
10-K/A Document

Amendment to Annual report pursuant to section 13 and 15(d)

Acc-no: 0001193125-24-108802 (34 Act) Size: 538 KB		 Apr-24-2024

001-37347

24867275
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0001171843-24-001382 (34 Act) Size: 5342 KB		 Mar-15-2024

001-37347

24754331
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001171843-24-000656 (34 Act) Size: 41 KB		 Feb-07-2024

005-88810

24603271
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001171843-24-000655 (34 Act) Size: 35 KB		 Feb-07-2024

005-88810

24603122
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001171843-24-000654 (34 Act) Size: 48 KB		 Feb-07-2024

005-88810

24603120
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000950170-24-002316 ( Act) Size: 107 KB		 Jan-05-2024

8-K Document

Current report filing

Acc-no: 0001171843-24-000056 (34 Act) Size: 283 KB		 Jan-04-2024

001-37347

24509878
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001171843-23-006944 (34 Act) Size: 3101 KB		 Nov-09-2023

001-37347

231391832
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001171843-23-005261 (34 Act) Size: 3241 KB		 Aug-11-2023

001-37347

231162228
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001209191-23-039579 ( Act) Size: 8 KB		 Jun-26-2023

Recent 20 filings. View all XBiotech Inc. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • XBiotech Inc. overview
  • XBiotech Inc. job
  • XBiotech Inc. stock
  • XBiotech Inc. ownership
  • XBiotech Inc. CEO
  • XBiotech Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Telix Pharmaceuticals Ltd
Update: May 18, 2024

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2448 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3393 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3966 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1618 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4067 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1377 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4668 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2961 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1846 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by